Chemical biology & drug designHumansLung NeoplasmsPrognosisCarcinomaSquamous Cell
The Immuno-Metabolic Crosstalk in Lung Squamous Cell Carcinoma: Prognostic Insights and Therapeutic Clues.
Haoyuan Xue, Hongwei Li, Songyan Han, Xiaqin Zhang, Tong Liu, Peng Bu, Hua Liang
Published: 202610.1111/cbdd.70253
Abstract
Lung squamous cell carcinoma (LUSC) has a poor prognosis due to the lack of effective targeted therapies, and its incidence has increased dramatically in recent years, creating an urgent need for new prognostic markers. Given that tumor immune and me…
Preview only. Read the full abstract at the source